Patents
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
11/2007
11/07/2007CN101066334A Chinese medicine composition for eliminating oral bad smell and its prepn
11/07/2007CN101066327A Functional health wine and its prepn process
11/07/2007CN101066326A Chinese medicine for treating kidney deficiency and its prepn
11/07/2007CN101066324A Chinese medicine composition for treating erosion of mucous membrane of oral cavity during menstruation
11/07/2007CN101066323A Sanhuang heat clearing away cold decoction
11/07/2007CN101066308A Medicine for treating hepatitis B and its prepn
11/07/2007CN101066302A Phlegm eliminating and indigestion relieving whiteflower hogfennel bolus
11/07/2007CN101066300A Cold decoction of four ingredients
11/07/2007CN101066298A Chinese medicine powder for treating portacaval mucositis
11/07/2007CN101066291A Chinese medicine composition for transquilizing, warming Yang, benefiting Qi and nourishing heart and its prepn
11/07/2007CN101066286A Coastal glehnia root extract with function of antagonizing gastric ulcer and its prepn
11/07/2007CN101066282A Oral medicine for treating gastropathy
11/07/2007CN101066279A Chewing tablet of proton pump inhibitor
11/07/2007CN101066276A Pyrimidine nucleotide precursors for treatment of systemic inflammation and inflammatory hepatitis
11/07/2007CN101066275A Mangiferin-berberine composition
11/07/2007CN101066274A Prepn process of double salt potassium D-aminogluconate sulfate
11/07/2007CN101066262A Statins for the treatment of viral influenza infections
11/07/2007CN101066260A Coenzyme Q10 emulsion and its freeze dried prepn and their prepn process
11/07/2007CN101066257A Licorice extract for treating oral sores
11/07/2007CN101066251A Dispersed tablet of proton pump inhibitor
11/07/2007CN101066250A Medicated leaven-malt bolus
11/07/2007CN101066152A Instant ginger-haw beverage and its prepn process
11/07/2007CN101066145A Sweet papaya beverage
11/07/2007CN101066126A Health food suitable for middle aged and old women
11/07/2007CN101066124A Coca-cola produced with natural Chinese herbal medicine
11/07/2007CN101066094A Recipe of mixed concentrated feed with bovine gastrin
11/07/2007CN101066085A Health tea composition
11/07/2007CN101066083A Health tea of aizoon stonecrop herb
11/07/2007CN101066079A Highland barley tea and its making process
11/07/2007CN100347293C Dedifferentiated, programmable stem cells of monocytic origin, and their production and use
11/07/2007CN100347281C 蜘蛛保健酒及其制备方法 Spider health wine and its preparation method
11/07/2007CN100347186C Deoxycholic acid derivatives for the treatment of acute dysfunctions of portal and hepatic venous circulation
11/07/2007CN100347169C 喹唑啉衍生物 Quinazoline derivatives
11/07/2007CN100347167C Process for producing substituted 2-(2-pyridylmethye)sulfinye-1H-benzinmidazoles
11/07/2007CN100347158C Bicyclic compound
11/07/2007CN100347151C Novel aminobenzoephenones
11/07/2007CN100346823C Enamel matrix protein compositions for modulating immune response
11/07/2007CN100346821C Medicinal capsule for treating liver and gallbladder diseases and its preparing process
11/07/2007CN100346806C Capsule comprising Chinese caterpillar fungus, royal jelly and matrimony vine
11/07/2007CN100346791C Controlled and released preparation of kurarinone detained in stomach
11/07/2007CN100346789C Use of nk-1 receptor antagonists for the treatment of brain, spinal or nerve injury
11/07/2007CN100346783C Sustained released malotilate preparation for hepa titis and cirrhosis
11/07/2007CN100346779C Liquid pharmaceutical composition
11/07/2007CN100346762C Oral hygiene system and method of treatment
11/06/2007US7291731 7-(3-Pyridyl)-1,7-diazaspiro-[4,4]nonane and its salts and proline amides; capable of affecting nicotinic cholinergic receptors, e.g., as modulators of specific nicotinic receptor subtypes; neuroprotective agents
11/06/2007US7291709 LSR (Lipolysis Stimulated Receptor); for the prevention and/or treatment of pathologies and/or of pathogeneses such as obesity and anorexia, hyperlipidemias, atherosclerosis, diabetes, hypertension
11/06/2007US7291644 For therapy and prophylaxis of allergic disorder, diseases accompanied with itching, secondary diseases generated by behaviors caused by itching, inflammation, chronic obstructive pulmonary disease, ischemic reperfusion disorder, pleuritis complicated by rheumatoid arthritis, cerebrovascular disease
11/06/2007US7291635 Protein tyrosine phosphatase 1B inhibitors alone or incombination with other antidiabetic, antilipemic, anticholesterol or hypotensive agents
11/06/2007US7291634 N-substituted-benzyl-N-(hydroxyaminocarbonylmethyl)cycloalkyl(alk)oxybenzenesulfonamides, e.g., 2-[(cyclopropylmethoxy-benzenesulfonyl)-(4-[1,2,3]triazol-1-yl-benzyl)-amino]-N-hydroxy-acetamide; treating diseases mediated by matrix-degrading metalloproteinases, in particular hyperproliferative diseases
11/06/2007US7291633 nicotinic alpha 7 receptor and 5-HT3 or 5-HT6 receptor; control of cholinergic and dopaminergic neurotransmission; disorders of the central nervous system and serotonergic hyperactivity; psychiatric and neurodegenerativce disorders; antiemetics during chemotherapy
11/06/2007US7291630 Azaindoles as inhibitors of c-Jun N-terminal kinases
11/06/2007US7291613 Inhibitors of p38 kinase
11/06/2007US7291608 Anti-inflammatory 17.β.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.α
11/06/2007US7291588 Immunogenic detoxified mutant E. coli LT-A toxin
11/06/2007US7291353 Anti-peptic ulcer activity of an extract of a flower of Woodfordia fruticosa
11/06/2007US7291334 antibodies that bind to immunogens for diagnosis of enterotoxigenic E. coli infections such as traveler's diarrhea; kits
11/06/2007US7291330 MD-1 inhibitors as immune suppressants
11/06/2007CA2388564C Caspase inhibitor
11/06/2007CA2385538C Recombinant adenoviral vectors and their utilization in the treatment of various types of hepatic, renal and pulmonary fibrosis and hypertrophic scars
11/06/2007CA2363713C Lantibiotic
11/06/2007CA2170236C Inducing antibody response against self-proteins with the aid of foreign t-cell epitopes
11/01/2007WO2007122975A1 Hgf precursor protein mutant and activated form thereof
11/01/2007WO2007122885A1 Interleukin production regulator, pharmaceutical composition or food comprising the interleukin production regulator, and method for production of the interleukin production regulator
11/01/2007WO2007122820A1 Diagnostic agent and therapeutic agent for pancreatic cancer
11/01/2007WO2007122813A1 Solid preparation for oral application
11/01/2007WO2007122812A1 Therapeutic agent for inflammatory bowel disease
11/01/2007WO2007122801A1 Gip secretion inhibitor
11/01/2007WO2007122686A1 Benzimidazole compounds
11/01/2007WO2007122382A2 Lycopene for the treatment of metabolic dysfunction
11/01/2007WO2007121807A1 Paediatric amino acid solution for parenteral nutrition
11/01/2007WO2007103187A3 8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
11/01/2007WO2007077510A3 Muscarinic receptor antagonists
11/01/2007WO2007072503A3 Combinations for managing inflammation and associated disorders
11/01/2007WO2007059515A3 Compositions of lipoxygenase inhibitors
11/01/2007WO2007046699A3 Method for stimulating intestinal barrier integrity after non-natural birth
11/01/2007WO2005000402A3 Anti-adhesion composites and methods os use thereof
11/01/2007WO2002090332A3 Novel aeylheteroalkylaminε derivatives
11/01/2007US20070255061 5-Fluoro-, Chloro-and Cyano-Pyridin-2-Yl-Tetrazoles as Ligands of the Metabotropic Glutamate Receptor-5
11/01/2007US20070254924 Salts of benzimidazole compound and use thereof
11/01/2007US20070254917 Intracellular receptor modulator compounds and methods
11/01/2007US20070254912 Benzimidazolyl-pyridine compounds for inflammation and immune-related uses
11/01/2007US20070254904 schizophrenia, emesis, anxiety and depression, irritable bowel syndrome (IBS), circadian rhythm disturbances, pre-eclampsia, nociception, neuropathic pain, pancreatitis, neurogenic inflammation, asthma, chronic obstructive pulmonary disease (COPD) and urinary incontinence
11/01/2007US20070254899 Soluble salts of thieno[2,3-d]pyrimidine derivatives
11/01/2007US20070254891 Crystalline forms of 4-(2-fluorophenyl)-6-methyl-2-(piperazin-1-yl)thieno[2,3-d]pyrimidine
11/01/2007US20070254890 4(Phenyl-Piperazinyl-Methyl) Benzamide Derivatives and Their Use for the Treatment of Pain or Gastrointestinal Disorders
11/01/2007US20070254886 N-[5-bromo-3-({3-[2-(dimethylamino)ethoxy]-4-methoxybenzyl}oxy)pyridin-2-yl]-4-methylbenzenesulfonamide, used for prevention and/or treatment of infections, inflammatory and/or allergic diseases
11/01/2007US20070254876 Glucuronate salt of a piperazine compound
11/01/2007US20070254875 Androgen Receptor Modulator Compounds and Methods
11/01/2007US20070254874 gastrointestinal disorders, urinary tract disorders such as hyperactive bladder, and cardiovascular disorders without side effects related to CNS activity; acid moiety makes drug unable to cross the blood-brain barrier; carboxy, phosphonic, sulfonic, or phosphoric acid derivative of piboserod (DDL-6001)
11/01/2007US20070254837 Treatment for Necrotizing Enterocolitis
11/01/2007US20070254833 Compositions and methods for treating diverticular disease
11/01/2007US20070254828 Pharmaceutical composition with healing activity comprising at least one soluble dextran derivative and at least one platelet-derived growth factor
11/01/2007US20070254055 Therapeutic Avenanthramide Compounds
11/01/2007US20070254031 Rapidly disintegrable solid preparation
11/01/2007US20070253975 Methods for preventing strokes by inducing tolerance to E-selectin
11/01/2007US20070253934 New strain of lactic acid bacterium and edible compositions, drugs and veterinary products containing it
11/01/2007US20070253902 Treatment for inflammatory bowel disease
11/01/2007US20070253898 Polymer based radionuclide containing particulate material
11/01/2007CA2650699A1 Diagnostic agent and therapeutic agent for pancreatic cancer
11/01/2007CA2649800A1 Hgf precursor protein variant and active protein thereof